On July 26, 2024, the eleventh Ageing Analysis and Drug Discovery assembly needed to cease registrations after reaching full capability. It bought out two weeks quicker than in 2023, a month previous to the beginning of the convention.
The convention is a non-profit volunteer-run occasion organized and hosted by the College of Copenhagen. It brings collectively high lecturers in getting old analysis, executives and scientists of massive pharmaceutical and biotechnology corporations, buyers, media and startups. In 2024, over 40 startups sponsored the convention demonstrating speedy development of the Longevity Biotechnology Business.
eleventh ARDD will function the primary Healthspan XPrize Summit, the $101 million prize devoted to groups conducting human healthspan scientific trials to speed up getting old analysis at scale.
“XPRIZE Healthspan is getting down to revolutionize the way in which we take into consideration and deal with getting old via the event of therapeutics that focus on organic getting old somewhat than illness,” stated Jamie Justice, Ph.D., Govt Director of XPRIZE Healthspan, XPRIZE. “In an effort to accomplish this, we’d like companions like ARDD to assist carry collectively world thought leaders that may create a future the place wholesome getting old is made potential for everybody.”
“I’m extraordinarily enthusiastic about this 12 months’s ARDD. We now have a stellar tutorial lineup and an extremely robust presence from main corporations within the getting old area. This 12 months the presence of pharma corporations together with Lilly, Lundbeck, Novartis, Regeneron and lots of others have been strengthened and we’re tremendous excited that XPRIZE will host their XPRIZE Healthspan Group Summit at ARDD. We’re persevering with to supply 3 journey grants for younger students to attend ARDD and provides beneficiant poster awards for the highest poster displays. This version of ARDD is shaping as much as be a improbable convention. Tickets are restricted so we encourage everybody to enroll early to safe a spot in Copenhagen. I very a lot look ahead to seeing previous and new buddies right here in Copenhagen.” stated Morten Scheibye-Knudsen, MD, Ph.D., College of Copenhagen.
“I’m genuinely thrilled concerning the upcoming ARDD convention this 12 months! Constructing on the unbelievable success and full bookings of final 12 months’s occasion, this 12 months guarantees once more distinctive alternatives to attach with good minds, fostering collaboration and showcasing groundbreaking analysis. What makes this 12 months much more particular is that we’re eagerly welcoming much more pharmaceutical corporations to hitch us on this journey. However that’s not all – we’re proud to announce our collaboration with XPRIZE. So, mark your calendar and be part of us at ARDD2024.” stated Daniela Bakula, Ph.D., College of Copenhagen.
“Launched 4 years in the past, Longevity Medication Day, as an integral half on the ARDD Convention, has quickly expanded from a workshop to a complete Longevity Medication Monitor. This monitor provides a dynamic discussion board for physicians, authorities officers, and key stakeholders to discover the most recent developments and set new requirements within the evolving area of longevity medication.” stated Prof. Evelyne Bischof, organizer of ARDD Longevity Medication Monitor.
“The ARDD convention was established to carry high lecturers with the highest-level of credibility along with the biopharmaceutical corporations and buyers. And for 11 years in a row the convention grew in measurement and in prominence. And now that large pharma corporations realized the worth of concentrating on power circumstances like weight problems and metabolic illnesses and are going into muscle losing and neurology, it grew to become essentially the most premium occasion within the area. I’m blissful to see that this 12 months it bought out quicker than final 12 months and the variety of sponsoring startups has elevated. Tier 3 sponsorships bought out quicker than registrations and subsequent 12 months, we anticipate much more startups becoming a member of the sector”, stated Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medication.
About Ageing Analysis and Drug Discovery Convention
At ARDD, leaders within the getting old, longevity, and drug discovery area will describe the most recent progress within the molecular, mobile and organismal foundation of getting old and the seek for interventions. Moreover, the assembly will embody opinion leaders in AI to debate the most recent advances of this know-how within the biopharmaceutical sector and the way this may be utilized to interventions. Notably, this 12 months we may have a special occasion referred to as Longevity Medication Day, particularly for physicians the place the modern data of scientific interventions for wholesome longevity shall be described. ARRD intends to bridge scientific, tutorial and industrial analysis and foster collaborations that can end in sensible options to one in every of humanity’s most difficult issues: getting old. Our quest? To increase the wholesome lifespan of everybody on the planet.
